271 related articles for article (PubMed ID: 26645356)
1. Dissociation of recombinant prion autocatalysis from infectivity.
Noble GP; Supattapone S
Prion; 2015; 9(6):405-11. PubMed ID: 26645356
[TBL] [Abstract][Full Text] [Related]
2. A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers.
Noble GP; Wang DW; Walsh DJ; Barone JR; Miller MB; Nishina KA; Li S; Supattapone S
PLoS Pathog; 2015 Jun; 11(6):e1005017. PubMed ID: 26125623
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human prion protein inhibits prion propagation in vitro.
Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
[TBL] [Abstract][Full Text] [Related]
4. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
5. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
6. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
7. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
8. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
9. Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins.
Imamura M; Kato N; Okada H; Yoshioka M; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
PLoS One; 2013; 8(12):e82538. PubMed ID: 24367521
[TBL] [Abstract][Full Text] [Related]
10. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
11. Autocatalytic self-propagation of misfolded prion protein.
Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
[TBL] [Abstract][Full Text] [Related]
12. On safari with PrP: prion diseases of animals.
Westaway D; Carlson GA; Prusiner SB
Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755
[TBL] [Abstract][Full Text] [Related]
13. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
14. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro.
Kim JI; Surewicz K; Gambetti P; Surewicz WK
FEBS Lett; 2009 Nov; 583(22):3671-5. PubMed ID: 19854187
[TBL] [Abstract][Full Text] [Related]
15. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
18. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
Fischer M; Rülicke T; Raeber A; Sailer A; Moser M; Oesch B; Brandner S; Aguzzi A; Weissmann C
EMBO J; 1996 Mar; 15(6):1255-64. PubMed ID: 8635458
[TBL] [Abstract][Full Text] [Related]
19. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
[TBL] [Abstract][Full Text] [Related]
20. A systematic investigation of production of synthetic prions from recombinant prion protein.
Schmidt C; Fizet J; Properzi F; Batchelor M; Sandberg MK; Edgeworth JA; Afran L; Ho S; Badhan A; Klier S; Linehan JM; Brandner S; Hosszu LL; Tattum MH; Jat P; Clarke AR; Klöhn PC; Wadsworth JD; Jackson GS; Collinge J
Open Biol; 2015 Dec; 5(12):150165. PubMed ID: 26631378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]